
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current STTK market cap is 38.15M. The company's latest EPS is USD -1.5743 and P/E is -0.51.
Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 714k | 1.12M | 1.61M | 3M | 0 |
Operating Income | -18.95M | -20.04M | -22.96M | -17.92M | -19.64M |
Net Income | -17.69M | -18.5M | -21.55M | -16.68M | -18.68M |
Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 9.93M | 30.02M | 652k | 1.66M | 5.72M |
Operating Income | -36.93M | -45.27M | -103.33M | -91.96M | -80.57M |
Net Income | -36.6M | -44.97M | -101.95M | -87.3M | -75.41M |
Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 159.56M | 146.34M | 128.61M | 111.72M | 91.05M |
Total Liabilities | 14.86M | 17.52M | 18M | 15.14M | 11.42M |
Total Equity | 144.71M | 128.81M | 110.62M | 96.58M | 79.63M |
Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 348.99M | 298.59M | 205.32M | 159.56M | 91.05M |
Total Liabilities | 39.13M | 26.8M | 29.17M | 14.86M | 11.42M |
Total Equity | 309.86M | 271.79M | 176.16M | 144.71M | 79.63M |
Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -81.23M | -16.16M | -27.08M | -43.15M | -60.52M |
Investing | 110.86M | -33.28M | -38.69M | -39.51M | -8.51M |
Financing | 48.62M | -184k | 836k | 859k | 787k |
Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -33.66M | -57.12M | -94.5M | -81.23M | -60.52M |
Investing | -146.32M | -10.44M | 49.44M | 110.86M | -8.51M |
Financing | 330.87M | 1.93M | 171k | 48.62M | 787k |
Market Cap | 38.15M |
Price to Earnings Ratio | -0.51 |
Price to Sales Ratio | 6.7 |
Price to Cash Ratio | 0.67 |
Price to Book Ratio | 0.48 |
Dividend Yield | - |
Shares Outstanding | 47.9M |
Average Volume (1 week) | 131.15k |
Average Volume (1 Month) | 323.27k |
52 Week Change | -92.61% |
52 Week High | 11.76 |
52 Week Low | 0.69215 |
Spread (Intraday) | 0.23 (24.47%) |
Company Name | Shattuck Labs Inc |
Address |
108 lakeland ave dover, delaware 19901 |
Website | https://www.shattucklabs.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions